Blood test may replace painful heart biopsies for transplant patients
NCT ID NCT02672683
First seen Nov 20, 2025 · Last updated May 07, 2026 · Updated 16 times
Summary
This study looked at whether a simple blood test measuring tiny molecules called microRNAs can spot early signs of rejection in heart transplant patients. Researchers compared the blood test results with standard heart biopsies in 461 participants. If accurate, this approach could offer a less invasive way to monitor transplant health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
PARCC/ INSERM U970, Team 4, Xavier Jouven, Cardiovascular epidemiology and sudden death, Georges Pompidou European Hospital,
Paris, 75015, France
Conditions
Explore the condition pages connected to this study.